ScholarMate
English简体中文繁體中文
客服热线:400-1616-289
登录注册
期刊论文

Trajectories of protein intake and 28-day mortality in critically ill patients: A secondary analysis of a cluster-randomized controlled trial

Lin, Jiajia; Chen, Wensong; Ye, Xianghong; Lv, Cheng; Liu, Yang; Jiang, Xingwei; Tong, Zhihui; Liu, Yuxiu; Ke, Lu*; Li, Weiqin; Li, Jieshou*南方医科大学; 南京大学
CLINICAL NUTRITION2022-8DOI: 10.1016/j.clnu.2022.05.017
4被引11阅读
引用收藏
分享

摘要

Background & aims: The optimal protein intake approach during the early phase of critical illness remains controversial. This study aimed to evaluate the association between different trajectories of protein intake and 28-day mortality in a cohort of critically ill patients. Methods: The NEED trial is a multicenter, cluster-randomized controlled trial assessing the impact of an actively implemented evidence-based nutrition guideline on mortality in critically ill patients. This secondary analysis included the patients who stayed in ICU for at least seven days. Group-based trajectory modeling was applied to identify subgroups with similar protein intake trajectories in this cohort. Cox proportional hazards models were used to analyze the impact of different trajectories on 28-day mortality. Results: Overall, 2191 patients were included for analysis. A distinct triple-group trajectory of protein intake was identified, with 919 patients categorized into the low-level protein intake group, 1146 the medium-level group, and 126 the high-level group. The mean daily protein intake from the low-to highlevel protein intake group during the first week of enrollment were 0.38 ?? 0.14, 0.8 ?? 0.18, and 1.68 ?? 0.39 g/kg/d, respectively. Compared with the medium-level protein intake group, the low-level or high-level protein intake group was associated with significantly increased 28-day mortality (hazard ratio [HR] = 1.348, 95% confidence interval [CI]: 1.067-1.704; HR = 2.291, 95% CI: 1.533-3.423, respectively). After controlling for potential confounders, the adjusted HRs were 1.365 (95% CI: 1.032-1.807) for the low-level group and 1.921 (95% CI: 1.274-2.896) for the high-level group. However, when taking energy intake into account, low-level protein intake was no longer related to mortality. In contrast, the detrimental effects of high-level protein intake remain tenable (Adjusted HR = 2.324, 95% CI: 1.524-3.543, P < 0.001). Conclusions: Low-level or high-level protein intake in the early phase of critical illness was associated with increased 28-day mortality than medium-level protein intake. However, when adjusted for energy intake, low-level protein intake in the early phase was no longer associated with increased 28-day mortality. ?? 2022 Elsevier Ltd and European Society for Clinical Nutrition and Metabolism.

学科与关键词

关键词
Protein intakeGroup-based trajectory modelingMortalityCritical illnessNutritional support
相关
加载中…

文献加载失败,请重试

重试

发表信息

论文状态
公开发表
期刊
CLINICAL NUTRITION
发表日期
2022-08
卷期
第 41 卷, 第 8 期
页码
1644-1650
DOI
10.1016/j.clnu.2022.05.017
语言
ENGLISH
期刊等级
2区
成果收录
SCIE
资助标注
National Natural Science Foundation of China [82070665]

作者

  • L

    Lin, Jiajia (第一作者)

    nanjing univ

  • C

    Chen, Wensong

    nanjing med univ

查看全部 11 位作者收起作者
  • Y

    Ye, Xianghong

    nanjing univ

  • L

    Lv, Cheng

    nanjing univ

  • L

    Liu, Yang

    southeast univ

  • J

    Jiang, Xingwei

    southeast univ

  • T

    Tong, Zhihui

    nanjing univ

  • L

    Liu, Yuxiu

    southern med univ · nanjing med univ

  • K

    Ke, Lu (通讯)

    nanjing univ

  • L

    Li, Weiqin

    nanjing univ

  • L

    Li, Jieshou (通讯)

    nanjing univ

登录解锁更多功能

  • 收藏这篇,随时在“我的 · 收藏”找回
  • 认领你的成果,生成推广素材
  • 关注作者获取最新成果
  • 加入项目组、协同写作
注册 / 登录

产品服务

  • 科研之友
  • 创新城
  • 科创云

服务支持

  • 帮助中心
  • 隐私政策
  • 服务条款

联系方式

在线客服:【】
客服热线:400-1616-289
电子邮箱:support@scholarmate.com

关注或下载科研之友

微信二维码
微信公众号
客户端下载二维码
下载客户端
科研成果科研人员科研机构科研动态爱瑞思软件

©2026 深圳市科研之友网络服务有限公司

公安备案图标粤公网安备 44030502000213
粤ICP备 16046710 号粤B2-20110417